Schouten, Philip C., Richters, Lisa, Vis, Daniel J., Kommoss, Stefan, van Dijk, Ewald, Ernst, Corinna ORCID: 0000-0001-7756-8815, Kluin, Roelof J. C., Marme, Frederik ORCID: 0000-0002-6591-3367, Lips, Esther H., Schmidt, Sandra, Scheerman, Esther, Prieske, Katharina, van Deurzen, Carolien H. M., Burges, Alexander, Ewing-Graham, Patricia C., Dietrich, Dimo, Jager, Agnes, de Gregorio, Nikolaus, Hauke, Jan ORCID: 0000-0001-8236-4075, du Bois, Andreas, Nederlof, Petra M., Wessels, Lodewyk F., Hahnen, Eric, Harter, Philipp, Linn, Sabine C. and Schmutzler, Rita K. (2021). Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial. Clin. Cancer Res., 27 (23). S. 6559 - 6570. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Full text not available from this repository.

Abstract

Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunken centroid classifiers predictive for mutation status and response to therapy, targeting homologous recombination deficiency (HRD). Therefore, we investigated BRCA1- and BRCA2-like classification in ovarian cancer, aiming to acquire classifiers with similar properties as those in breast cancer. Experimental Design: We analyzed DNA copy-number profiles of germline BRCA1- and BRCA2-mutant ovarian cancers and control tumors and observed that existing breast cancer classifiers did not sufficiently predict mutation status. Hence, we trained new shrunken centroid classifiers on this set and validated them in the independent The Cancer Genome Atlas dataset. Subsequently, we assessed BRCA1/2-like classification and obtained germline and tumor mutation and methylation status of cancer predisposition genes, among them several involved in HR repair, of 300 ovarian cancer samples derived from the consecutive cohort trial AGO-TR1 (NCT02222883). Results: The detection rate of the BRCA1-like classifier for BRCA1 mutations and promoter hypermethylation was 95.6%. The BRCA2-like classifier performed less accurately, likely due to a smaller training set. Furthermore, three quarters of the BRCA1/2-like tumors could be explained by (epi)genetic alterations in BRCA1/2, germline RAD51C mutations and alterations in other genes involved in HR. Around half of the non-BRCA-mutated ovarian cancer cases displayed a BRCA-like phenotype. Conclusions: The newly trained classifiers detected most BRCA-mutated and methylated cancers and all tumors harboring a RAD51C germline mutations. Beyond that, we found an additional substantial proportion of ovarian cancers to be BRCA-like.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Schouten, Philip C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Richters, LisaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vis, Daniel J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kommoss, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van Dijk, EwaldUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ernst, CorinnaUNSPECIFIEDorcid.org/0000-0001-7756-8815UNSPECIFIED
Kluin, Roelof J. C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marme, FrederikUNSPECIFIEDorcid.org/0000-0002-6591-3367UNSPECIFIED
Lips, Esther H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmidt, SandraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Scheerman, EstherUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Prieske, KatharinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van Deurzen, Carolien H. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Burges, AlexanderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ewing-Graham, Patricia C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dietrich, DimoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jager, AgnesUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
de Gregorio, NikolausUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hauke, JanUNSPECIFIEDorcid.org/0000-0001-8236-4075UNSPECIFIED
du Bois, AndreasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nederlof, Petra M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wessels, Lodewyk F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hahnen, EricUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Harter, PhilippUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Linn, Sabine C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmutzler, Rita K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-602711
DOI: 10.1158/1078-0432.CCR-21-1673
Journal or Publication Title: Clin. Cancer Res.
Volume: 27
Number: 23
Page Range: S. 6559 - 6570
Date: 2021
Publisher: AMER ASSOC CANCER RESEARCH
Place of Publication: PHILADELPHIA
ISSN: 1557-3265
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
BREAST-CANCER; MAINTENANCE THERAPY; GENOMIC LOSS; OLAPARIB; PROFILE; REPAIR; CHEMOTHERAPY; MULTICENTER; CARCINOMA; RUCAPARIBMultiple languages
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60271

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item